Hutchin Hill Capital’s GSK GSK Stock Holding History

Hutchin Hill Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-448,000	Closed	-$25.7M	–	606
2014 Q3	$25.7M	Buy	+448,000	New	+$27.5M	0.97%	28

Other funds holding GSK

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hutchin Hill Capital's GSK Position: Q4 2014 in Review

Hutchin Hill Capital sold out of GSK (GSK) in Q4 2014, closing a stake of 448,000 shares — an estimated $25.7M sold.

Hutchin Hill Capital first reported a position in GSK in Q3 2014 and held it in 1 quarter. The position peaked at $25.7M in Q3 2014. 728 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

Hutchin Hill Capital reported no remaining GSK position as of Q4 2014 after selling out during the quarter.
Hutchin Hill Capital sold 448,000 GSK shares in Q4 2014, an estimated $25.7M.
Hutchin Hill Capital first reported a position in GSK in Q3 2014 and held it in 1 quarter.
Hutchin Hill Capital's GSK position peaked at $25.7M in Q3 2014.
728 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Hutchin Hill Capital's 13F filing for Q4 2014, filed 17 Feb 2015.